NCT05358938 2026-02-06
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Active not recruiting
Clinical Trials
6 trialsNCT03244176 2024-07-30
AvR-CHOP
Austin Health
Phase EARLY_PHASE1 Active not recruiting
NCT06204614 2024-01-12
Drug Screening Using IMD in Bladder Cancer
Brigham and Women's Hospital
Phase EARLY_PHASE1 Unknown
NCT04065555 2022-07-29
Intratumoral Microdosing of TAK-981 in Head and Neck Cancer
Presage Biosciences
Phase EARLY_PHASE1 Completed
NCT03158883 2021-10-20
UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients
University of California, Davis
Phase EARLY_PHASE1 Completed
NCT03481920 2019-08-22
A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer
PH Research, S.L.
Phase EARLY_PHASE1 Terminated